Aditxt and Evofem Secure Merger to Empower Women’s Health
Aditxt and Evofem Biosciences have agreed to merge, creating an alliance focused on accelerating health innovations in women’s healthcare....
Silexion Therapeutics Unveils Pioneering RNAi Technology from Silexion Therapeutics for Revolutionizing the Fight Against KRAS-Driven Cancers
Silexion’s proprietary LODER™ platform enables targeted oncogene silencing, using siRNA to block the production of oncogenic proteins. This approach...
Innate Pharma’s Monalizumab NeoCOAST-2 Phase 2 Trial Reports Encouraging Outcomes in Early-Stage Lung Cancer
The NeoCOAST-2 trial evaluated the efficacy and safety of treatments in patients with early-stage non-small cell lung cancersmall cell...
How to Employ the Best Strategies From Your Clinical Trial Technology
Welcome to the Veeva R&D and Quality Summit. Today, we have the pleasure of speaking with Rylan Collins, VP...
AstraZeneca TROP2 Biomarker Predicts Lung Cancer Treatment Outcomes
An exploratory analysis of the TROPION-Lung01 phase 3 trial revealed TROP2 expression, measured using AstraZeneca’s computational pathology platform, as...
Summit Therapeutics’s Remarkable Cancer Breakthrough: New Treatment Reduces Disease Progression by 49%
Summit Therapeutics and Akeso announced positive results from the Phase III HARMONi-2 trial, evaluating ivonescimab, an investigational bispecific antibody,...
Connected Clinical Trial Applications, Quality, and Site Collaboration
Welcome to the Veeva R&D Quality Summit, where we explore the latest innovations in clinical trials. Today, Richard Young,...
Paige Unveils Alba: The AI Co-Pilot Revolutionizing Disease Diagnostics and Treatment
Paige, a leader in artificial intelligence (AI) technology, introduces Paige Alba™, a clinical-grade AI co-pilot designed to transform personalized...
FDA Letter Supports Amprion’s Revolutionary α-Synuclein Test
The U.S. Food & Drug Administration (FDA) recently issued a Letter of Support (LoS) endorsing the use of the...
SEQSTER and PatientsLikeMe Partner for Enhanced Patient Health Insights
SEQSTER, a healthcare technology company, and PatientsLikeMe (PLM), an engagement platform, have partnered to harness the power of patient...